Metraipolis › archive › dc_6b2b60429ef4

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42211735
DOI
10.1016/j.mmr.2026.100038
License (as archived)
solo-consultazione
Archived
2026-11-01T14:43:07.233Z
SHA-256 of the archived text
d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686
Stable URL of this page
https://metraipolis.com/documento/dc_6b2b60429ef4

How to cite

The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735 — Europe PMC (en), https://europepmc.org/article/MED/42211735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b2b60429ef4 (Metraipolis archive dc_6b2b60429ef4, sha256 d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686)
BibTeX
@misc{dc6b2b60429ef4,
  title = {The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42211735},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b2b60429ef4; sha256 d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211735. Agents can read the archived copy with the MCP tool read_document.